SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-085933
Filing Date
2024-10-07
Accepted
2024-10-07 16:45:09
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0216529-s3_pasithea.htm S-3 243114
2 OPINION OF LOWENSTEIN SANDLER LLP ea021652901ex5-1_pasi.htm EX-5.1 9862
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - MARCUM LLP ea021652901ex23-1_pasi.htm EX-23.1 2840
4 FILING FEE TABLE ea021652901ex-fee_pasi.htm EX-FILING FEES 14660
5 GRAPHIC image_001.jpg GRAPHIC 19970
6 GRAPHIC ex5-1_001.jpg GRAPHIC 11997
7 GRAPHIC ex5-1_002.jpg GRAPHIC 13074
  Complete submission text file 0001213900-24-085933.txt   333901
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282532 | Film No.: 241358308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)